Ebastine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 13.10.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

IndicationThis section has been translated automatically.

Symptomatic treatment of seasonal and perennial allergic rhinitis with or without allergic conjunctivitis, itching, to reduce the formation of new wheals in urticaria.

Pregnancy/nursing periodThis section has been translated automatically.

Should not be used during pregnancy (insufficient data available). Contraindicated during lactation (do not use, because due to insufficient data it is not known whether the active substance passes into breast milk).

Dosage and method of useThis section has been translated automatically.

  • Allergic rhinitis: children > 12 years and adults: 1 x/day 10 mg p.o. In case of severe symptoms and perennial allergic rhinitis, increase the dose to 20 mg p.o. once/day.
  • Urticaria: adults, adolescents > 18 years: once/day 10 mg p.o.

Undesirable effectsThis section has been translated automatically.

Occasionally or rarely headaches, fatigue, dry mouth, pharyngitis, abdominal pain, indigestion, weakness, nosebleeds, rhinitis, sinusitis, nausea, insomnia, etc.

InteractionsThis section has been translated automatically.

Ketoconazole or erythromycin: higher ebastine plasma levels and an increase of the QTc interval of about 10 msec longer than after the sole administration of ketoconazole or erythromycin.

ContraindicationThis section has been translated automatically.

Severe liver or kidney failure.

Notice!

Do not use on children or patients under 18 years of age (insufficient data available)!

PreparationsThis section has been translated automatically.

Ebastel® 10 mg film-coated tablets, Ebastel® 20 mg film-coated tablets

Authors

Last updated on: 13.10.2021